If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...

President Trump is likely to embrace the Medicare drug price negotiations that was initiated under the Biden administration, though the president could make some tweaks to put his own spin on it. The ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...